glp-1 news november 2025 Wegovy maker Novo Nordisk makes major announcement glp-1 news november 3 2025

The study also assessed secondary outcomes, including changes in body weight and the percentage of patients achieving specific HbA1c levels

Research study evidence supporting their effectiveness includes phytoniosomes demonstrating enhanced therapeutic activity, lyophilization ensuring stable capsules with excellent shelf life, and enabling controlled release mechanisms in topical administration with improved permeation and drug release [125,126,127]

Viability of probiotic microorganisms in cheese during production and storage: a review

The weight loss secondarily improves insulin sensitivity, creating a beneficial cycle